These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. PSGR2, a novel G-protein coupled receptor, is overexpressed in human prostate cancer. Weng J, Wang J, Hu X, Wang F, Ittmann M, Liu M. Int J Cancer; 2006 Mar 15; 118(6):1471-80. PubMed ID: 16206286 [Abstract] [Full Text] [Related]
3. Prostate specific G protein coupled receptor is associated with prostate cancer prognosis and affects cancer cell proliferation and invasion. Cao W, Li F, Yao J, Yu J. BMC Cancer; 2015 Nov 18; 15():915. PubMed ID: 26582057 [Abstract] [Full Text] [Related]
4. PSGR, a novel prostate-specific gene with homology to a G protein-coupled receptor, is overexpressed in prostate cancer. Xu LL, Stackhouse BG, Florence K, Zhang W, Shanmugam N, Sesterhenn IA, Zou Z, Srikantan V, Augustus M, Roschke V, Carter K, McLeod DG, Moul JW, Soppett D, Srivastava S. Cancer Res; 2000 Dec 01; 60(23):6568-72. PubMed ID: 11118034 [Abstract] [Full Text] [Related]
8. INSL3 in the benign hyperplastic and neoplastic human prostate gland. Klonisch T, Müller-Huesmann H, Riedel M, Kehlen A, Bialek J, Radestock Y, Holzhausen HJ, Steger K, Ludwig M, Weidner W, Hoang-Vu C, Hombach-Klonisch S. Int J Oncol; 2005 Aug 01; 27(2):307-15. PubMed ID: 16010410 [Abstract] [Full Text] [Related]
9. STEAP1 is overexpressed in prostate cancer and prostatic intraepithelial neoplasia lesions, and it is positively associated with Gleason score. Gomes IM, Arinto P, Lopes C, Santos CR, Maia CJ. Urol Oncol; 2014 Jan 01; 32(1):53.e23-9. PubMed ID: 24239460 [Abstract] [Full Text] [Related]
10. Klf4 transcription factor is expressed in the cytoplasm of prostate cancer cells. Le Magnen C, Bubendorf L, Ruiz C, Zlobec I, Bachmann A, Heberer M, Spagnoli GC, Wyler S, Mengus C. Eur J Cancer; 2013 Mar 01; 49(4):955-63. PubMed ID: 23089465 [Abstract] [Full Text] [Related]
11. Prostate cancer antigen-1 as a potential novel marker for prostate cancer. Liu BQ, Wu YD, Li PH, Wei JX, Zhang T, Liu RL. Asian J Androl; 2007 Nov 01; 9(6):821-6. PubMed ID: 17968469 [Abstract] [Full Text] [Related]
13. PSGR and PCA3 as biomarkers for the detection of prostate cancer in urine. Rigau M, Morote J, Mir MC, Ballesteros C, Ortega I, Sanchez A, Colás E, Garcia M, Ruiz A, Abal M, Planas J, Reventós J, Doll A. Prostate; 2010 Dec 01; 70(16):1760-7. PubMed ID: 20672322 [Abstract] [Full Text] [Related]
14. Differential display code 3 (DD3/PCA3) in prostate cancer diagnosis. Klecka J, Holubec L, Pesta M, Topolcan O, Hora M, Eret V, Finek J, Chottova-Dvorakova M, Babjuk M, Novak K, Stolz J. Anticancer Res; 2010 Feb 01; 30(2):665-70. PubMed ID: 20332487 [Abstract] [Full Text] [Related]
17. Decreased NKX3.1 protein expression in focal prostatic atrophy, prostatic intraepithelial neoplasia, and adenocarcinoma: association with gleason score and chromosome 8p deletion. Bethel CR, Faith D, Li X, Guan B, Hicks JL, Lan F, Jenkins RB, Bieberich CJ, De Marzo AM. Cancer Res; 2006 Nov 15; 66(22):10683-90. PubMed ID: 17108105 [Abstract] [Full Text] [Related]